Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Спонтанно наступившая беременность у пациентки с преждевременной недостаточностью яичников после процедуры интраовариального введения аутологичной плазмы, обогащенной тромбоцитами. Клинический случай
Спонтанно наступившая беременность у пациентки с преждевременной недостаточностью яичников после процедуры интраовариального введения аутологичной плазмы, обогащенной тромбоцитами. Клинический случай
Краевая Е.Е., Макарова Н.П., Бабаян А.А., Калинина Е.А. Спонтанно наступившая беременность у пациентки с преждевременной недостаточностью яичников после процедуры интраовариального введения аутологичной плазмы, обогащенной тромбоцитами. Клинический случай. Гинекология. 2021;23(6):597–600.
DOI: 10.26442/20795696.2021.6.201244
DOI: 10.26442/20795696.2021.6.201244
DOI: 10.26442/20795696.2021.6.201244
________________________________________________
DOI: 10.26442/20795696.2021.6.201244
Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Аннотация
Несмотря на современные достижения в области репродуктивной медицины, в настоящее время не существует эффективного способа повышения овариального резерва. Зачастую добиться наступления беременности у пациенток с преждевременной недостаточностью яичников удается лишь при использовании донорского генетического материала, поэтому сниженный овариальный резерв является крайне актуальной проблемой репродукции. В отделение вспомогательных технологий в лечении бесплодия им. Б.В. Леонова ФГБУ «НМИЦ АГП им. акад. В.И. Кулакова» обратилась пациентка 31 года с преждевременной недостаточностью яичников, ановуляторным бесплодием, неудачной попыткой экстракорпорального оплодотворения в анамнезе. Пациентке проведена процедура интраовариального введения собственной плазмы, обогащенной тромбоцитами (platelet rich plasma – PRP) с целью улучшения функции яичников. Спустя 1 мес после проведения процедуры у пациентки наступила самопроизвольная беременность. Процедура введения PRP может быть перспективной для пациенток с яичниковой недостаточностью. По данным литературы и собственному опыту, после введения в яичники PRP наблюдается тенденция к увеличению количества антральных фолликулов по данным ультразвукового исследования, что может свидетельствовать о некотором временном повышении овариального резерва и улучшении репродуктивного прогноза.
Ключевые слова: сниженный овариальный резерв, бесплодие, вспомогательные репродуктивные технологии, обогащенная тромбоцитами плазма
Keywords: decreased ovarian reserve, infertility, assisted reproductive technologies, platelet-rich plasma, case report
Ключевые слова: сниженный овариальный резерв, бесплодие, вспомогательные репродуктивные технологии, обогащенная тромбоцитами плазма
________________________________________________
Keywords: decreased ovarian reserve, infertility, assisted reproductive technologies, platelet-rich plasma, case report
Полный текст
Список литературы
1. Женское бесплодие (современные подходы к диагностике и лечению. Клинические рекомендации Министерства здравоохранения РФ. 2019. Режим доступа: https://roag-portal.ru/projects_gynecology. Ссылка активна на 10.05.2021 [Zhenskoe besplodie (sovremennye podkhody k diagnostike i lecheniiu. Klinicheskie rekomendatsii Ministerstva zdravookhraneniia RF. 2019. Available at: https://roag-portal.ru/projects_gynecology. Accessed: 10.05.2021 [(in Russian)].
2. Tal R, Seif DB. Ovarian reserve testing: a user's guide. Am J Obstet Gynecol. 2017;217(2):129-40. DOI:10.1016/j.ajog.2017.02.027
3. Салимова М.Д., Наделяева Я.Г., Данусевич И.Н. Современные представления о клинико-диагностических критериях преждевременной недостаточности яичников (обзор литературы). Acta Biomedica Scientifica. 2020;5(6):42-50 [Salimova MD, Nadelyaeva YaG, Danusevich IN. Modern Concepts of Clinical and Diagnostic Criteria for Premature Ovarian Failure (Literature Review). Acta Biomedica Scientifica. 2020;5(6):42-50 (in Russian)]. DOI:10.29413/ABS.2020-5.6.5
4. Попова К.А., Леонтьев А.А. Роль экзогенных и эндогенных факторов в формировании преждевременной недостаточности яичников в структуре бесплодия у женщин. Синергия наук. 2020;53:832-9 [Popova KA, Leontyev AA. The role of exogenic and endogenous factors in the formation of premature ovarian insufficiency in the structure of infertility in women. Sinergiia nauk. 2020;53:832-9 (in Russian)].
5. Елисеенко Л.Н., Дивакова Т.С. Влияние хирургического лечения эндометриом на функциональное состояние яичника. Охрана материнства и детства. 2017;2(30):38-42 [Eliseenko LN, Divakova TS. The effect of surgical treatment of endometrium on the functional state of the ovary. Okhrana materinstva i detstva. 2017;2(30):38-42 (in Russian)].
6. Назаренко Т.А., Калинина Е.А., Корнеева И.Е., Мартиросян Я.О. Сохранение репродуктивной функции онкологических больных. Реалии сегодняшнего дня. Медицинский оппонент. 2019;3(7):40-4 [Nazarenko TA, Kalinina EA, Korneeva IE, Martirosyan YaO. Preservation of the Reproductive Function in Patients with Cancer. The Realities of Today (Literature Review). Medical Opponent. 2019;3(7):40-4 (in Russian)].
7. Позднякова А.А. Преждевременная недостаточность яичников: от диагностике к профилактике и лечению последствий заболевания. Главный врач Юга России. 2020;4(74):24-7 [Pozdnyakova AA. Premature failure of the ovaries: from diagnostics to prevention and treatment of consequences of the disease. Glavnyi vrach Iuga Rossii. 2020;4(74):24-7 (in Russian)].
8. Yatsenko SA, Rajkovic А. Genetics of human female infertility. Biol Reprod. 2019;101(3):549-66. DOI:10.1093/biolre/ioz084
9. Hart RJ. Physiological Aspects of Female Fertility: Role of the Environment, Modern Lifestyle, and Genetics. Physiol Rev. 2016;96(3):873-909. DOI:10.1152/physrev.00023.2015
10. Xu Y, Nisenblat V, Lu C, et al. Pretreatment with coenzyme Q10 improves ovarian response and embryo quality in low-prognosis young women with decreased ovarian reserve: a randomized controlled trial. Reprod Biol Endocrinol. 2018;16(1):29. DOI:10.1186/s12958-018-0343-0
11. Hu KL, Ye X, Wang S, Zhang D. Melatonin Application in Assisted Reproductive Technology: A Systematic Review and Meta-Analysis of Randomized Trials. Front Endocrinol (Lausanne). 2020;27(11):160. DOI:10.3389/fendo.2020.00160
12. The Eshre Guideline Group On Ovarian Stimulation; Bosch E, Broer S, Griesinger G, et al. ESHRE guideline: ovarian stimulation for IVF/ICSI. Hum Reprod Open. 2020;2020(2):hoaa009. DOI:10.1093/hropen/hoaa009
13. Wu PI, Diaz R, Borg-Stein J, et al. Platelet-Rich Plasma. Phys Med Rehabil Clin N Am. 2016;27(4):825-53. DOI:10.1016/j.pmr.2016.06.002
14. Martínez-Martínez A, Ruiz-Santiago F, García-Espinosa J. Platelet-rich plasma: myth or reality? Radiologia (Engl Ed). 2018;60(6):465-75 (in Spanish). DOI:10.1016/j.rx.2018.08.006
15. Cohen PR, Riahi RR. Platelet-Rich Plasma and Genital Rejuvenation. Skinmed. 2019;17(4):272-4.
16. Bos-Mikich A, de Oliveira R, Frantz N. Platelet-rich plasma therapy and reproductive medicine. J Assist Reprod Genet. 2018;35(5):753-6. DOI:10.1007/s10815-018-1159-8
17. Eftekhar M, Neghab N, Naghshineh E, Khani P. Can autologous platelet rich plasma expand endometrial thickness and improve pregnancy rate during frozen-thawed embryo transfer cycle? A randomized clinical trial. Taiwan J Obstet Gynecol. 2018;57(6):810-3. DOI:10.1016/j.tjog.2018.10.007
18. Гохберг Я.А., Макарова Н.П., Бабаян А.А., Калинина Е.А. Роль различных факторов воздействия на эндометрий в повышении эффективности программ вспомогательных репродуктивных технологий. Акушерство и гинекология. 2021;1:28-34 [Gokhberg YaA, Makarova NP, Babayan AA, Kalinina EA. The role of various factors affecting the endometrium in enhancing the effectiveness of assisted reproductive technology programs. Akusherstvo i ginekologya. 2021;1:28-34 (in Russian)]. DOI:10.18565/aig.2021.1.28-34
19. Petryk N, Petryk М. Ovarian Rejuvenation Through Platelet-Rich Autologous Plasma (PRP) – a Chance to Have a Baby Without Donor Eggs, Improving the Life Quality of Women Suffering from Early Menopause Without Synthetic Hormonal Treatment. Reprod Sci. 2020;27(11):1975-82. DOI:10.1007/s43032-020-00266-8
20. Sills ES, Samuel HW. Autologous activated platelet-rich plasma injection into adult human ovary tissue: molecular mechanism, analysis, and discussion of reproductive response. Biosci Rep. 2019;39(6):BSR20190805. DOI:10.1042/BSR20190805
21. Zou K, Yuan Z, Yang Z, et al. Production of offspring from a germline stem cell line derived from neonatal ovaries. Nat Cell Biol. 2009;11(5):631-6. DOI:10.1038/ncb1869
22. Bukovsky A, Caudle MR, Svetlikova M, et al. Oogenesis in adult mammals, including humans: a review. Endocrine. 2005;26(3):301-16. DOI:10.1385/ENDO:26:3:301
23. Pantos K, Nitsos N, Kokkali G, et al. Ovarian rejuvenation and folliculogenesis reactivation in peri-menopausal women after autologous platelet-rich plasma treatment. Abstracts, ESHRE 32nd Annual Meeting, Helsinki, 2016.
24. Cakiroglu Y, Saltik A, Yuceturk A, et al. Effects of intraovarian injection of autologous platelet rich plasma on ovarian reserve and IVF outcome parameters in women with primary ovarian insufficiency. Aging (Albany NY). 2020;12(11):10211-22. DOI:10.18632/aging.103403
25. Melo P, Navarro C, Jones C, et al. The use of autologous platelet-rich plasma (PRP) versus no intervention in women with low ovarian reserve undergoing fertility treatment: a non-randomized interventional study. J Assist Reprod Genet. 2020;37(4):855-63. DOI:10.1007/s10815-020-01710-z
26. Sills ES, Rickers NS, Li X, Palermo GD. First data on in vitro fertilization and blastocyst formation after intraovarian injection of calcium gluconate-activated autologous platelet rich plasma. Gynecol Endocrinol. 2018;34(9):756-60. DOI:10.1080/09513590.2018.1445219
27. Sfakianoudis K, Simopoulou M, Grigoriadis S. Reactivating Ovarian Function through Autologous Platelet-Rich Plasma Intraovarian Infusion: Pilot Data on Premature Ovarian Insufficiency, Perimenopausal, Menopausal, and Poor Responder Women. J Clin Med. 2020;9(6):1809. DOI:10.3390/jcm9061809
28. Panda SR, Sachan S, Hota S. A Systematic Review Evaluating the Efficacy of Intra-Ovarian Infusion of Autologous Platelet-Rich Plasma in Patients With Poor Ovarian Reserve or Ovarian Insufficiency. Cureus. 2020;12(12):e12037. DOI:10.7759/cureus.12037
29. Hsu CC, Hsu L, Hsu I, et al. Live Birth in Woman With Premature Ovarian Insufficiency Receiving Ovarian Administration of Platelet-Rich Plasma (PRP) in Combination With Gonadotropin: A Case Report. Front Endocrinol (Lausanne). 2020;11:50. DOI:10.3389/fendo.2020.00050
30. Aflatoonian A, Lotfi M, Saeed L, Tabibnejad N. Effects of Intraovarian Injection of Autologous Platelet-Rich Plasma on Ovarian Rejuvenation in Poor Responders and Women with Primary Ovarian Insufficiency. Reprod Sci. 2021;28(7):2050-9. DOI:10.1007/s43032-021-00483-9
31. Alves R, Grimalt R. A Review of Platelet-Rich Plasma: History, Biology, Mechanism of Action, and Classification. Skin Appendage Disord. 2018;4(1):18-24. DOI:10.1159/000477353
2. Tal R, Seif DB. Ovarian reserve testing: a user's guide. Am J Obstet Gynecol. 2017;217(2):129-40. DOI:10.1016/j.ajog.2017.02.027
3. Salimova MD, Nadelyaeva YaG, Danusevich IN. Modern Concepts of Clinical and Diagnostic Criteria for Premature Ovarian Failure (Literature Review). Acta Biomedica Scientifica. 2020;5(6):42-50 (in Russian). DOI:10.29413/ABS.2020-5.6.5
4. Popova KA, Leontyev AA. The role of exogenic and endogenous factors in the formation of premature ovarian insufficiency in the structure of infertility in women. Sinergiia nauk. 2020;53:832-9 (in Russian).
5. Eliseenko LN, Divakova TS. The effect of surgical treatment of endometrium on the functional state of the ovary. Okhrana materinstva i detstva. 2017;2(30):38-42 (in Russian).
6. Nazarenko TA, Kalinina EA, Korneeva IE, Martirosyan YaO. Preservation of the Reproductive Function in Patients with Cancer. The Realities of Today (Literature Review). Medical Opponent. 2019;3(7):40-4 (in Russian).
7. Pozdnyakova AA. Premature failure of the ovaries: from diagnostics to prevention and treatment of consequences of the disease. Glavnyi vrach Iuga Rossii. 2020;4(74):24-7 (in Russian).
8. Yatsenko SA, Rajkovic А. Genetics of human female infertility. Biol Reprod. 2019;101(3):549-66. DOI:10.1093/biolre/ioz084
9. Hart RJ. Physiological Aspects of Female Fertility: Role of the Environment, Modern Lifestyle, and Genetics. Physiol Rev. 2016;96(3):873-909. DOI:10.1152/physrev.00023.2015
10. Xu Y, Nisenblat V, Lu C, et al. Pretreatment with coenzyme Q10 improves ovarian response and embryo quality in low-prognosis young women with decreased ovarian reserve: a randomized controlled trial. Reprod Biol Endocrinol. 2018;16(1):29. DOI:10.1186/s12958-018-0343-0
11. Hu KL, Ye X, Wang S, Zhang D. Melatonin Application in Assisted Reproductive Technology: A Systematic Review and Meta-Analysis of Randomized Trials. Front Endocrinol (Lausanne). 2020;27(11):160. DOI:10.3389/fendo.2020.00160
12. The Eshre Guideline Group On Ovarian Stimulation; Bosch E, Broer S, Griesinger G, et al. ESHRE guideline: ovarian stimulation for IVF/ICSI. Hum Reprod Open. 2020;2020(2):hoaa009. DOI:10.1093/hropen/hoaa009
13. Wu PI, Diaz R, Borg-Stein J, et al. Platelet-Rich Plasma. Phys Med Rehabil Clin N Am. 2016;27(4):825-53. DOI:10.1016/j.pmr.2016.06.002
14. Martínez-Martínez A, Ruiz-Santiago F, García-Espinosa J. Platelet-rich plasma: myth or reality? Radiologia (Engl Ed). 2018;60(6):465-75 (in Spanish). DOI:10.1016/j.rx.2018.08.006
15. Cohen PR, Riahi RR. Platelet-Rich Plasma and Genital Rejuvenation. Skinmed. 2019;17(4):272-4.
16. Bos-Mikich A, de Oliveira R, Frantz N. Platelet-rich plasma therapy and reproductive medicine. J Assist Reprod Genet. 2018;35(5):753-6. DOI:10.1007/s10815-018-1159-8
17. Eftekhar M, Neghab N, Naghshineh E, Khani P. Can autologous platelet rich plasma expand endometrial thickness and improve pregnancy rate during frozen-thawed embryo transfer cycle? A randomized clinical trial. Taiwan J Obstet Gynecol. 2018;57(6):810-3. DOI:10.1016/j.tjog.2018.10.007
18. Gokhberg YaA, Makarova NP, Babayan AA, Kalinina EA. The role of various factors affecting the endometrium in enhancing the effectiveness of assisted reproductive technology programs. Akusherstvo i ginekologya. 2021;1:28-34 (in Russian). DOI:10.18565/aig.2021.1.28-34
19. Petryk N, Petryk М. Ovarian Rejuvenation Through Platelet-Rich Autologous Plasma (PRP) – a Chance to Have a Baby Without Donor Eggs, Improving the Life Quality of Women Suffering from Early Menopause Without Synthetic Hormonal Treatment. Reprod Sci. 2020;27(11):1975-82. DOI:10.1007/s43032-020-00266-8
20. Sills ES, Samuel HW. Autologous activated platelet-rich plasma injection into adult human ovary tissue: molecular mechanism, analysis, and discussion of reproductive response. Biosci Rep. 2019;39(6):BSR20190805. DOI:10.1042/BSR20190805
21. Zou K, Yuan Z, Yang Z, et al. Production of offspring from a germline stem cell line derived from neonatal ovaries. Nat Cell Biol. 2009;11(5):631-6. DOI:10.1038/ncb1869
22. Bukovsky A, Caudle MR, Svetlikova M, et al. Oogenesis in adult mammals, including humans: a review. Endocrine. 2005;26(3):301-16. DOI:10.1385/ENDO:26:3:301
23. Pantos K, Nitsos N, Kokkali G, et al. Ovarian rejuvenation and folliculogenesis reactivation in peri-menopausal women after autologous platelet-rich plasma treatment. Abstracts, ESHRE 32nd Annual Meeting, Helsinki, 2016.
24. Cakiroglu Y, Saltik A, Yuceturk A, et al. Effects of intraovarian injection of autologous platelet rich plasma on ovarian reserve and IVF outcome parameters in women with primary ovarian insufficiency. Aging (Albany NY). 2020;12(11):10211-22. DOI:10.18632/aging.103403
25. Melo P, Navarro C, Jones C, et al. The use of autologous platelet-rich plasma (PRP) versus no intervention in women with low ovarian reserve undergoing fertility treatment: a non-randomized interventional study. J Assist Reprod Genet. 2020;37(4):855-63. DOI:10.1007/s10815-020-01710-z
26. Sills ES, Rickers NS, Li X, Palermo GD. First data on in vitro fertilization and blastocyst formation after intraovarian injection of calcium gluconate-activated autologous platelet rich plasma. Gynecol Endocrinol. 2018;34(9):756-60. DOI:10.1080/09513590.2018.1445219
27. Sfakianoudis K, Simopoulou M, Grigoriadis S. Reactivating Ovarian Function through Autologous Platelet-Rich Plasma Intraovarian Infusion: Pilot Data on Premature Ovarian Insufficiency, Perimenopausal, Menopausal, and Poor Responder Women. J Clin Med. 2020;9(6):1809. DOI:10.3390/jcm9061809
28. Panda SR, Sachan S, Hota S. A Systematic Review Evaluating the Efficacy of Intra-Ovarian Infusion of Autologous Platelet-Rich Plasma in Patients With Poor Ovarian Reserve or Ovarian Insufficiency. Cureus. 2020;12(12):e12037. DOI:10.7759/cureus.12037
29. Hsu CC, Hsu L, Hsu I, et al. Live Birth in Woman With Premature Ovarian Insufficiency Receiving Ovarian Administration of Platelet-Rich Plasma (PRP) in Combination With Gonadotropin: A Case Report. Front Endocrinol (Lausanne). 2020;11:50. DOI:10.3389/fendo.2020.00050
30. Aflatoonian A, Lotfi M, Saeed L, Tabibnejad N. Effects of Intraovarian Injection of Autologous Platelet-Rich Plasma on Ovarian Rejuvenation in Poor Responders and Women with Primary Ovarian Insufficiency. Reprod Sci. 2021;28(7):2050-9. DOI:10.1007/s43032-021-00483-9
31. Alves R, Grimalt R. A Review of Platelet-Rich Plasma: History, Biology, Mechanism of Action, and Classification. Skin Appendage Disord. 2018;4(1):18-24. DOI:10.1159/000477353
2. Tal R, Seif DB. Ovarian reserve testing: a user's guide. Am J Obstet Gynecol. 2017;217(2):129-40. DOI:10.1016/j.ajog.2017.02.027
3. Салимова М.Д., Наделяева Я.Г., Данусевич И.Н. Современные представления о клинико-диагностических критериях преждевременной недостаточности яичников (обзор литературы). Acta Biomedica Scientifica. 2020;5(6):42-50 [Salimova MD, Nadelyaeva YaG, Danusevich IN. Modern Concepts of Clinical and Diagnostic Criteria for Premature Ovarian Failure (Literature Review). Acta Biomedica Scientifica. 2020;5(6):42-50 (in Russian)]. DOI:10.29413/ABS.2020-5.6.5
4. Попова К.А., Леонтьев А.А. Роль экзогенных и эндогенных факторов в формировании преждевременной недостаточности яичников в структуре бесплодия у женщин. Синергия наук. 2020;53:832-9 [Popova KA, Leontyev AA. The role of exogenic and endogenous factors in the formation of premature ovarian insufficiency in the structure of infertility in women. Sinergiia nauk. 2020;53:832-9 (in Russian)].
5. Елисеенко Л.Н., Дивакова Т.С. Влияние хирургического лечения эндометриом на функциональное состояние яичника. Охрана материнства и детства. 2017;2(30):38-42 [Eliseenko LN, Divakova TS. The effect of surgical treatment of endometrium on the functional state of the ovary. Okhrana materinstva i detstva. 2017;2(30):38-42 (in Russian)].
6. Назаренко Т.А., Калинина Е.А., Корнеева И.Е., Мартиросян Я.О. Сохранение репродуктивной функции онкологических больных. Реалии сегодняшнего дня. Медицинский оппонент. 2019;3(7):40-4 [Nazarenko TA, Kalinina EA, Korneeva IE, Martirosyan YaO. Preservation of the Reproductive Function in Patients with Cancer. The Realities of Today (Literature Review). Medical Opponent. 2019;3(7):40-4 (in Russian)].
7. Позднякова А.А. Преждевременная недостаточность яичников: от диагностике к профилактике и лечению последствий заболевания. Главный врач Юга России. 2020;4(74):24-7 [Pozdnyakova AA. Premature failure of the ovaries: from diagnostics to prevention and treatment of consequences of the disease. Glavnyi vrach Iuga Rossii. 2020;4(74):24-7 (in Russian)].
8. Yatsenko SA, Rajkovic А. Genetics of human female infertility. Biol Reprod. 2019;101(3):549-66. DOI:10.1093/biolre/ioz084
9. Hart RJ. Physiological Aspects of Female Fertility: Role of the Environment, Modern Lifestyle, and Genetics. Physiol Rev. 2016;96(3):873-909. DOI:10.1152/physrev.00023.2015
10. Xu Y, Nisenblat V, Lu C, et al. Pretreatment with coenzyme Q10 improves ovarian response and embryo quality in low-prognosis young women with decreased ovarian reserve: a randomized controlled trial. Reprod Biol Endocrinol. 2018;16(1):29. DOI:10.1186/s12958-018-0343-0
11. Hu KL, Ye X, Wang S, Zhang D. Melatonin Application in Assisted Reproductive Technology: A Systematic Review and Meta-Analysis of Randomized Trials. Front Endocrinol (Lausanne). 2020;27(11):160. DOI:10.3389/fendo.2020.00160
12. The Eshre Guideline Group On Ovarian Stimulation; Bosch E, Broer S, Griesinger G, et al. ESHRE guideline: ovarian stimulation for IVF/ICSI. Hum Reprod Open. 2020;2020(2):hoaa009. DOI:10.1093/hropen/hoaa009
13. Wu PI, Diaz R, Borg-Stein J, et al. Platelet-Rich Plasma. Phys Med Rehabil Clin N Am. 2016;27(4):825-53. DOI:10.1016/j.pmr.2016.06.002
14. Martínez-Martínez A, Ruiz-Santiago F, García-Espinosa J. Platelet-rich plasma: myth or reality? Radiologia (Engl Ed). 2018;60(6):465-75 (in Spanish). DOI:10.1016/j.rx.2018.08.006
15. Cohen PR, Riahi RR. Platelet-Rich Plasma and Genital Rejuvenation. Skinmed. 2019;17(4):272-4.
16. Bos-Mikich A, de Oliveira R, Frantz N. Platelet-rich plasma therapy and reproductive medicine. J Assist Reprod Genet. 2018;35(5):753-6. DOI:10.1007/s10815-018-1159-8
17. Eftekhar M, Neghab N, Naghshineh E, Khani P. Can autologous platelet rich plasma expand endometrial thickness and improve pregnancy rate during frozen-thawed embryo transfer cycle? A randomized clinical trial. Taiwan J Obstet Gynecol. 2018;57(6):810-3. DOI:10.1016/j.tjog.2018.10.007
18. Гохберг Я.А., Макарова Н.П., Бабаян А.А., Калинина Е.А. Роль различных факторов воздействия на эндометрий в повышении эффективности программ вспомогательных репродуктивных технологий. Акушерство и гинекология. 2021;1:28-34 [Gokhberg YaA, Makarova NP, Babayan AA, Kalinina EA. The role of various factors affecting the endometrium in enhancing the effectiveness of assisted reproductive technology programs. Akusherstvo i ginekologya. 2021;1:28-34 (in Russian)]. DOI:10.18565/aig.2021.1.28-34
19. Petryk N, Petryk М. Ovarian Rejuvenation Through Platelet-Rich Autologous Plasma (PRP) – a Chance to Have a Baby Without Donor Eggs, Improving the Life Quality of Women Suffering from Early Menopause Without Synthetic Hormonal Treatment. Reprod Sci. 2020;27(11):1975-82. DOI:10.1007/s43032-020-00266-8
20. Sills ES, Samuel HW. Autologous activated platelet-rich plasma injection into adult human ovary tissue: molecular mechanism, analysis, and discussion of reproductive response. Biosci Rep. 2019;39(6):BSR20190805. DOI:10.1042/BSR20190805
21. Zou K, Yuan Z, Yang Z, et al. Production of offspring from a germline stem cell line derived from neonatal ovaries. Nat Cell Biol. 2009;11(5):631-6. DOI:10.1038/ncb1869
22. Bukovsky A, Caudle MR, Svetlikova M, et al. Oogenesis in adult mammals, including humans: a review. Endocrine. 2005;26(3):301-16. DOI:10.1385/ENDO:26:3:301
23. Pantos K, Nitsos N, Kokkali G, et al. Ovarian rejuvenation and folliculogenesis reactivation in peri-menopausal women after autologous platelet-rich plasma treatment. Abstracts, ESHRE 32nd Annual Meeting, Helsinki, 2016.
24. Cakiroglu Y, Saltik A, Yuceturk A, et al. Effects of intraovarian injection of autologous platelet rich plasma on ovarian reserve and IVF outcome parameters in women with primary ovarian insufficiency. Aging (Albany NY). 2020;12(11):10211-22. DOI:10.18632/aging.103403
25. Melo P, Navarro C, Jones C, et al. The use of autologous platelet-rich plasma (PRP) versus no intervention in women with low ovarian reserve undergoing fertility treatment: a non-randomized interventional study. J Assist Reprod Genet. 2020;37(4):855-63. DOI:10.1007/s10815-020-01710-z
26. Sills ES, Rickers NS, Li X, Palermo GD. First data on in vitro fertilization and blastocyst formation after intraovarian injection of calcium gluconate-activated autologous platelet rich plasma. Gynecol Endocrinol. 2018;34(9):756-60. DOI:10.1080/09513590.2018.1445219
27. Sfakianoudis K, Simopoulou M, Grigoriadis S. Reactivating Ovarian Function through Autologous Platelet-Rich Plasma Intraovarian Infusion: Pilot Data on Premature Ovarian Insufficiency, Perimenopausal, Menopausal, and Poor Responder Women. J Clin Med. 2020;9(6):1809. DOI:10.3390/jcm9061809
28. Panda SR, Sachan S, Hota S. A Systematic Review Evaluating the Efficacy of Intra-Ovarian Infusion of Autologous Platelet-Rich Plasma in Patients With Poor Ovarian Reserve or Ovarian Insufficiency. Cureus. 2020;12(12):e12037. DOI:10.7759/cureus.12037
29. Hsu CC, Hsu L, Hsu I, et al. Live Birth in Woman With Premature Ovarian Insufficiency Receiving Ovarian Administration of Platelet-Rich Plasma (PRP) in Combination With Gonadotropin: A Case Report. Front Endocrinol (Lausanne). 2020;11:50. DOI:10.3389/fendo.2020.00050
30. Aflatoonian A, Lotfi M, Saeed L, Tabibnejad N. Effects of Intraovarian Injection of Autologous Platelet-Rich Plasma on Ovarian Rejuvenation in Poor Responders and Women with Primary Ovarian Insufficiency. Reprod Sci. 2021;28(7):2050-9. DOI:10.1007/s43032-021-00483-9
31. Alves R, Grimalt R. A Review of Platelet-Rich Plasma: History, Biology, Mechanism of Action, and Classification. Skin Appendage Disord. 2018;4(1):18-24. DOI:10.1159/000477353
________________________________________________
2. Tal R, Seif DB. Ovarian reserve testing: a user's guide. Am J Obstet Gynecol. 2017;217(2):129-40. DOI:10.1016/j.ajog.2017.02.027
3. Salimova MD, Nadelyaeva YaG, Danusevich IN. Modern Concepts of Clinical and Diagnostic Criteria for Premature Ovarian Failure (Literature Review). Acta Biomedica Scientifica. 2020;5(6):42-50 (in Russian). DOI:10.29413/ABS.2020-5.6.5
4. Popova KA, Leontyev AA. The role of exogenic and endogenous factors in the formation of premature ovarian insufficiency in the structure of infertility in women. Sinergiia nauk. 2020;53:832-9 (in Russian).
5. Eliseenko LN, Divakova TS. The effect of surgical treatment of endometrium on the functional state of the ovary. Okhrana materinstva i detstva. 2017;2(30):38-42 (in Russian).
6. Nazarenko TA, Kalinina EA, Korneeva IE, Martirosyan YaO. Preservation of the Reproductive Function in Patients with Cancer. The Realities of Today (Literature Review). Medical Opponent. 2019;3(7):40-4 (in Russian).
7. Pozdnyakova AA. Premature failure of the ovaries: from diagnostics to prevention and treatment of consequences of the disease. Glavnyi vrach Iuga Rossii. 2020;4(74):24-7 (in Russian).
8. Yatsenko SA, Rajkovic А. Genetics of human female infertility. Biol Reprod. 2019;101(3):549-66. DOI:10.1093/biolre/ioz084
9. Hart RJ. Physiological Aspects of Female Fertility: Role of the Environment, Modern Lifestyle, and Genetics. Physiol Rev. 2016;96(3):873-909. DOI:10.1152/physrev.00023.2015
10. Xu Y, Nisenblat V, Lu C, et al. Pretreatment with coenzyme Q10 improves ovarian response and embryo quality in low-prognosis young women with decreased ovarian reserve: a randomized controlled trial. Reprod Biol Endocrinol. 2018;16(1):29. DOI:10.1186/s12958-018-0343-0
11. Hu KL, Ye X, Wang S, Zhang D. Melatonin Application in Assisted Reproductive Technology: A Systematic Review and Meta-Analysis of Randomized Trials. Front Endocrinol (Lausanne). 2020;27(11):160. DOI:10.3389/fendo.2020.00160
12. The Eshre Guideline Group On Ovarian Stimulation; Bosch E, Broer S, Griesinger G, et al. ESHRE guideline: ovarian stimulation for IVF/ICSI. Hum Reprod Open. 2020;2020(2):hoaa009. DOI:10.1093/hropen/hoaa009
13. Wu PI, Diaz R, Borg-Stein J, et al. Platelet-Rich Plasma. Phys Med Rehabil Clin N Am. 2016;27(4):825-53. DOI:10.1016/j.pmr.2016.06.002
14. Martínez-Martínez A, Ruiz-Santiago F, García-Espinosa J. Platelet-rich plasma: myth or reality? Radiologia (Engl Ed). 2018;60(6):465-75 (in Spanish). DOI:10.1016/j.rx.2018.08.006
15. Cohen PR, Riahi RR. Platelet-Rich Plasma and Genital Rejuvenation. Skinmed. 2019;17(4):272-4.
16. Bos-Mikich A, de Oliveira R, Frantz N. Platelet-rich plasma therapy and reproductive medicine. J Assist Reprod Genet. 2018;35(5):753-6. DOI:10.1007/s10815-018-1159-8
17. Eftekhar M, Neghab N, Naghshineh E, Khani P. Can autologous platelet rich plasma expand endometrial thickness and improve pregnancy rate during frozen-thawed embryo transfer cycle? A randomized clinical trial. Taiwan J Obstet Gynecol. 2018;57(6):810-3. DOI:10.1016/j.tjog.2018.10.007
18. Gokhberg YaA, Makarova NP, Babayan AA, Kalinina EA. The role of various factors affecting the endometrium in enhancing the effectiveness of assisted reproductive technology programs. Akusherstvo i ginekologya. 2021;1:28-34 (in Russian). DOI:10.18565/aig.2021.1.28-34
19. Petryk N, Petryk М. Ovarian Rejuvenation Through Platelet-Rich Autologous Plasma (PRP) – a Chance to Have a Baby Without Donor Eggs, Improving the Life Quality of Women Suffering from Early Menopause Without Synthetic Hormonal Treatment. Reprod Sci. 2020;27(11):1975-82. DOI:10.1007/s43032-020-00266-8
20. Sills ES, Samuel HW. Autologous activated platelet-rich plasma injection into adult human ovary tissue: molecular mechanism, analysis, and discussion of reproductive response. Biosci Rep. 2019;39(6):BSR20190805. DOI:10.1042/BSR20190805
21. Zou K, Yuan Z, Yang Z, et al. Production of offspring from a germline stem cell line derived from neonatal ovaries. Nat Cell Biol. 2009;11(5):631-6. DOI:10.1038/ncb1869
22. Bukovsky A, Caudle MR, Svetlikova M, et al. Oogenesis in adult mammals, including humans: a review. Endocrine. 2005;26(3):301-16. DOI:10.1385/ENDO:26:3:301
23. Pantos K, Nitsos N, Kokkali G, et al. Ovarian rejuvenation and folliculogenesis reactivation in peri-menopausal women after autologous platelet-rich plasma treatment. Abstracts, ESHRE 32nd Annual Meeting, Helsinki, 2016.
24. Cakiroglu Y, Saltik A, Yuceturk A, et al. Effects of intraovarian injection of autologous platelet rich plasma on ovarian reserve and IVF outcome parameters in women with primary ovarian insufficiency. Aging (Albany NY). 2020;12(11):10211-22. DOI:10.18632/aging.103403
25. Melo P, Navarro C, Jones C, et al. The use of autologous platelet-rich plasma (PRP) versus no intervention in women with low ovarian reserve undergoing fertility treatment: a non-randomized interventional study. J Assist Reprod Genet. 2020;37(4):855-63. DOI:10.1007/s10815-020-01710-z
26. Sills ES, Rickers NS, Li X, Palermo GD. First data on in vitro fertilization and blastocyst formation after intraovarian injection of calcium gluconate-activated autologous platelet rich plasma. Gynecol Endocrinol. 2018;34(9):756-60. DOI:10.1080/09513590.2018.1445219
27. Sfakianoudis K, Simopoulou M, Grigoriadis S. Reactivating Ovarian Function through Autologous Platelet-Rich Plasma Intraovarian Infusion: Pilot Data on Premature Ovarian Insufficiency, Perimenopausal, Menopausal, and Poor Responder Women. J Clin Med. 2020;9(6):1809. DOI:10.3390/jcm9061809
28. Panda SR, Sachan S, Hota S. A Systematic Review Evaluating the Efficacy of Intra-Ovarian Infusion of Autologous Platelet-Rich Plasma in Patients With Poor Ovarian Reserve or Ovarian Insufficiency. Cureus. 2020;12(12):e12037. DOI:10.7759/cureus.12037
29. Hsu CC, Hsu L, Hsu I, et al. Live Birth in Woman With Premature Ovarian Insufficiency Receiving Ovarian Administration of Platelet-Rich Plasma (PRP) in Combination With Gonadotropin: A Case Report. Front Endocrinol (Lausanne). 2020;11:50. DOI:10.3389/fendo.2020.00050
30. Aflatoonian A, Lotfi M, Saeed L, Tabibnejad N. Effects of Intraovarian Injection of Autologous Platelet-Rich Plasma on Ovarian Rejuvenation in Poor Responders and Women with Primary Ovarian Insufficiency. Reprod Sci. 2021;28(7):2050-9. DOI:10.1007/s43032-021-00483-9
31. Alves R, Grimalt R. A Review of Platelet-Rich Plasma: History, Biology, Mechanism of Action, and Classification. Skin Appendage Disord. 2018;4(1):18-24. DOI:10.1159/000477353
Авторы
Е.Е. Краевая*, Н.П. Макарова, А.А. Бабаян, Е.А. Калинина
ФГБУ «Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова» Минздрава России, Москва, Россия
*e_kraevaya@oparina4.ru
Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Moscow, Russia
*e_kraevaya@oparina4.ru
ФГБУ «Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова» Минздрава России, Москва, Россия
*e_kraevaya@oparina4.ru
________________________________________________
Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Moscow, Russia
*e_kraevaya@oparina4.ru
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.